{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:25:33Z","timestamp":1790504733772,"version":"4.1.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01210","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T13:18:43Z","timestamp":1594387123000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview"],"prefix":"10.3389","volume":"11","author":[{"given":"Alessio","family":"Romerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0952-7915(97)80152-5","article-title":"Innate immunity : impact on the adaptive immune response","volume":"9","author":"Medzhitov","year":"1997","journal-title":"Curr Opin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"781235","DOI":"10.1155\/2010\/781235","article-title":"Toll-like receptor signaling pathways - therapeutic opportunities","volume":"2010","author":"Mohan","year":"2010","journal-title":"Mediat Inflamm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","article-title":"Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation","volume":"165","author":"Vanaja","year":"2016","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.immuni.2016.11.007","article-title":"Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer","volume":"46","author":"Ryu","year":"2017","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cell.2006.03.047","article-title":"Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling","volume":"125","author":"Kagan","year":"2006","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2174\/1568026043388213","article-title":"Endotoxins : relationships between structure, function, and activity","volume":"4","author":"Brandenburg","year":"2004","journal-title":"Curr Top Med Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1179\/096805101101532675","article-title":"Bacterial lipopolysaccharides and innate immunity","volume":"7","author":"Alexander","year":"2001","journal-title":"J Endotoxin Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/chem.201403923","article-title":"Chemistry of lipid a: at the heart of innate immunity","volume":"21","author":"Molinaro","year":"2015","journal-title":"Chem Eur J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1128\/JB.181.16.4725-4733.1999","article-title":"Structures of gram-negative cell walls and their derived membrane vesicles","volume":"181","author":"Beveridge","year":"1999","journal-title":"J Bacteriol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.4049\/jimmunol.180.7.5067","article-title":"High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-\u03b1 production in human monocytes","volume":"180","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.str.2018.04.007","article-title":"A thermodynamic funnel drives bacterial lipopolysaccharide transfer in the TLR4 pathway","volume":"26","author":"Huber","year":"2018","journal-title":"Structure"},{"key":"B14","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1242\/jcs.115.12.2603","article-title":"Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation","volume":"115","author":"Triantafilou","year":"2002","journal-title":"J Cell Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1084\/jem.20060943","article-title":"Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages","volume":"174","author":"Powers","year":"2006","journal-title":"J Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Mackay","year":"2001","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1097\/01.CCM.0000288082.99980.90","article-title":"Expanding the global epidemiology of sepsis","volume":"35","author":"Cribbs","year":"2007","journal-title":"Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00328","article-title":"Toll-like receptor-4 modulation for cancer immunotherapy","volume":"5","author":"Awasthi","year":"2014","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.2741\/1712","article-title":"The toll-like receptor-nuclear factor \u03baB pathway in rheumatoid arthritis","volume":"10","author":"Andreakos","year":"2005","journal-title":"Front Biosci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1194\/jlr.R400015-JLR200","article-title":"Paying the price for pathogen protection: toll receptors in atherogenesis","volume":"46","author":"Tobias","year":"2005","journal-title":"J Lipid Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/med.21553","article-title":"Recent clinical trends in Toll-like receptor targeting therapeutics","volume":"39","author":"Anwar","year":"2019","journal-title":"Med Res Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*","volume":"38","author":"Rice","year":"2010","journal-title":"Crit Care Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4155\/fmc-2017-0172","article-title":"Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives","volume":"10","author":"Zaffaroni","year":"2018","journal-title":"Fut Med Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"86031","DOI":"10.18632\/oncotarget.20907","article-title":"Monophosphoryl lipid a attenuates radiation injury through TLR4 activation","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1016\/j.vaccine.2018.05.101","article-title":"A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model","volume":"36","author":"Gregg","year":"2018","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fimmu.2018.00301","article-title":"Molecular signatures of a TLR4 agonist-adjuvanted HIV-1 vaccine candidate in humans","volume":"9","author":"Anderson","year":"2018","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1039\/C7SC05323A","article-title":"Synthetic glycan-based TLR4 agonists targeting caspase-4\/11 for the development of adjuvants and immunotherapeutics","volume":"9","author":"Adanitsch","year":"2018","journal-title":"Chem Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/glia.23132","article-title":"E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord","volume":"65","author":"Church","year":"2017","journal-title":"Glia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.01050-17","article-title":"Synthetic toll-like receptor 4 (TLR4) and TLR7 ligands work additively via MyD88 to induce protective antiviral immunity in mice","volume":"91","author":"Goff","year":"2017","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.4049\/jimmunol.1800380","article-title":"Computationally designed bispecific MD2\/CD14 binding peptides show TLR4 agonist activity","volume":"201","author":"Michaeli","year":"2018","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/molecules23010102","article-title":"Rational design of a new class of toll-like receptor 4 (tlr4) tryptamine related agonists by means of the structure- and ligand-based virtual screening for vaccine adjuvant discovery","volume":"23","author":"Honegr","year":"2018","journal-title":"Molecules"},{"key":"B32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejmech.2017.12.074","article-title":"Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro","volume":"146","author":"Honegr","year":"2018","journal-title":"Eur J Med Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1073\/pnas.1719407115","article-title":"Molecular structural diversity of mitochondrial cardiolipins","volume":"115","author":"Oemer","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/eji.201444462","article-title":"Postulates for validating TLR4 agonists","volume":"45","author":"Man\u010dek-Keber","year":"2015","journal-title":"Eur J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1021\/acs.jmedchem.7b01803","article-title":"Structure-activity relationship in monosaccharide-based toll-like receptor 4 (TLR4) antagonists","volume":"61","author":"Facchini","year":"2018","journal-title":"J Med Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37421-w","article-title":"Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties","volume":"9","author":"Cochet","year":"2019","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/cmdc.201800505","article-title":"Disaccharide-based anionic amphiphiles as potent inhibitors of lipopolysaccharide-induced inflammation","volume":"13","author":"Borio","year":"2018","journal-title":"ChemMedChem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1021\/jm801333m","article-title":"Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization","volume":"52","author":"Piazza","year":"2009","journal-title":"J Med Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s12035-018-1145-2","article-title":"Selective toll-like receptor 4 antagonists prevent acute blood-brain barrier disruption after subarachnoid hemorrhage in mice","volume":"56","author":"Okada","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1021\/acs.jmedchem.7b00095","article-title":"Amphiphilic guanidinocalixarenes inhibit lipopolysaccharide (LPS)-and lectin-stimulated toll-like receptor 4 (TLR4) signaling","volume":"60","author":"Sestito","year":"2017","journal-title":"J Med Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1021\/acs.jcim.7b00717","article-title":"Dissecting the innate immune recognition of opioid inactive isomer (+)-naltrexone derived toll-like receptor 4 (TLR4) Antagonists","volume":"58","author":"Zhang","year":"2018","journal-title":"J Chem Inf Model."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1021\/acs.jmedchem.9b00061","article-title":"Linear and rationally designed stapled peptides abrogate TLR4 pathway and relieve inflammatory symptoms in rheumatoid arthritis rat model","volume":"62","author":"Achek","year":"2019","journal-title":"J Med Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.micpath.2018.11.007","article-title":"Protective effects of alpinetin on lipopolysaccharide\/D-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses","volume":"126","author":"Liu","year":"2019","journal-title":"Microb Pathog"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1007\/s12035-018-1280-9","article-title":"Ferulic acid rescues LPS-induced neurotoxicity via modulation of the TLR4 receptor in the mouse hippocampus","volume":"56","author":"Rehman","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid a as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00492-17","article-title":"Rationally designed TLR4 ligands for vaccine adjuvant discovery","volume":"8","author":"Gregg","year":"2017","journal-title":"MBio"},{"key":"B47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3762\/bjoc.14.3","article-title":"Aminosugar-based immunomodulator lipid A: synthetic approaches","volume":"14","author":"Zamyatina","year":"2017","journal-title":"Beilstein J Org Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0264-410X(02)00737-5","article-title":"Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice","volume":"21","author":"Przetak","year":"2003","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1016\/S0021-9258(18)33836-5","article-title":"Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium","volume":"257","author":"Qureshi","year":"1982","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/intimm\/dxt071","article-title":"The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4\/MD2 complex at the plasma membrane","volume":"26","author":"Tanimura","year":"2014","journal-title":"Int Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2165\/11206830-000000000-00000","article-title":"AS04-Adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix\u00ae)","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"B53","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tips.2017.06.002","article-title":"An overview of novel adjuvants designed for improving vaccine efficacy","volume":"38","author":"Bonam","year":"2017","journal-title":"Trends Pharmacol Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1073\/pnas.1218080110","article-title":"Modulating the innate immune response by combinatorial engineering of endotoxin","volume":"110","author":"Needham","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B55","volume-title":"Synthetic Glucopyranosyl Lipid Adjuvants","author":"Reed","year":"2014"},{"key":"B56","volume-title":"Disaccharide Synthetic Lipid Compounds and Uses Thereof","author":"Shaw","year":"2016"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS ONE"},{"key":"B58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.colsurfb.2009.08.022","article-title":"Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations","volume":"75","author":"Anderson","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0041144","article-title":"Glucopyranosyl lipid adjuvant (gla), a synthetic tlr4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with hivgp140","volume":"7","author":"Arias","year":"2012","journal-title":"PLoS ONE"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e84707","DOI":"10.1371\/journal.pone.0084707","article-title":"Glucopyranosyl lipid a adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen","volume":"9","author":"McKay","year":"2014","journal-title":"PLoS ONE"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1088631","DOI":"10.1080\/2162402X.2015.1088631","article-title":"Trial watch: immunostimulation with toll-like receptor agonists in cancer therapy","volume":"5","author":"Iribarren","year":"2016","journal-title":"OncoImmunology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4049\/jimmunol.1601145","article-title":"Intratumoral delivery of immunotherapy\u2014act locally, think globally","volume":"198","author":"Aznar","year":"2017","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1182\/blood.V126.23.820.820","article-title":"Intratumoral injection of TLR4 agonist (G100) leads to tumor regression of A20 lymphoma and induces abscopal responses","volume":"126","author":"Sagiv-Barfi","year":"2015","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1158\/1078-0432.CCR-18-0469","article-title":"Intratumoral G100, a TLR4 agonist, induces antitumor immune responses and tumor regression in patients with Merkel cell carcinoma","volume":"25","author":"Bhatia","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1038\/cti.2016.63","article-title":"A structure-function approach to optimizing TLR4 ligands for human vaccines","volume":"5","author":"Carter","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41541-019-0116-6","article-title":"The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine","volume":"4","author":"Liang","year":"2019","journal-title":"Npj Vaccines"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1126\/science.1240988","article-title":"Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock","volume":"341","author":"Hagar","year":"2013","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1128\/IAI.59.7.2351-2358.1991","article-title":"Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X","volume":"59","author":"Lam","year":"1991","journal-title":"Infect Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0171-2985(11)80346-3","article-title":"Agonists and antagonists for lipopolysaccharide-induced cytokines","volume":"187","author":"Flad","year":"1993","journal-title":"Immunobiology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1128\/IAI.66.12.5792-5798.1998","article-title":"Relationship of structure and biological activity of monosaccharide lipid A analogs to induction of nitric oxide production by murine macrophage RAW264","volume":"66","author":"Funatogawa","year":"1998","journal-title":"Infect Immun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1128\/IAI.67.12.6286-6292.1999","article-title":"Activity of monosaccharide lipid A analogs in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide","volume":"67","author":"Matsuura","year":"1999","journal-title":"Infect Immun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/cbic.201300588","article-title":"Modulation of CD14 and TLR4\u00d7MD-2 activities by a synthetic lipid A mimetic","volume":"15","author":"Cighetti","year":"2014","journal-title":"ChemBioChem"},{"key":"B73","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.phrs.2015.11.020","article-title":"Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model","volume":"103","author":"De Paola","year":"2016","journal-title":"Pharmacol Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"40791","DOI":"10.1038\/srep40791","article-title":"TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection","volume":"7","author":"Perrin-Cocon","year":"2017","journal-title":"Sci Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12118","article-title":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection","volume":"497","author":"Shirey","year":"2013","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B77","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/1753425918798904","article-title":"The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling","volume":"24","author":"Palmer","year":"2018","journal-title":"Innate Immun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/cmdc.201700694","article-title":"Co-administration of antimicrobial peptides enhances toll-like receptor 4 antagonist activity of a synthetic glycolipid","volume":"13","author":"Facchini","year":"2018","journal-title":"ChemMedChem"},{"key":"B79","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1128\/AAC.6.4.422","article-title":"Inactivation of endotoxin by polymyxin B","volume":"6","author":"Cooperstock","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1074\/jbc.M504327200","article-title":"Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides: peptide properties and plausible modes of action","volume":"281","author":"Rosenfeld","year":"2006","journal-title":"J Biol Chem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"26307","DOI":"10.1074\/jbc.M401231200","article-title":"Aggregates are the biologically active units of endotoxin","volume":"279","author":"Mueller","year":"2004","journal-title":"J Biol Chem"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.addr.2012.05.009","article-title":"Cationic lipids activate intracellular signaling pathways","volume":"64","author":"Lonez","year":"2012","journal-title":"Adv Drug Deliv Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.bcp.2010.06.019","article-title":"The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding","volume":"80","author":"Piazza","year":"2010","journal-title":"Biochem Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.molimm.2014.05.011","article-title":"Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles","volume":"63","author":"Calabrese","year":"2015","journal-title":"Mol Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/cbdd.12749","article-title":"Glycolipid-based TLR4 modulators and fluorescent probes: rational design, synthesis, and biological properties","volume":"88","author":"Ciaramelli","year":"2016","journal-title":"Chem Biol Drug Design"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08299-x","article-title":"TLR4-mediated placental pathology and pregnancy outcome in experimental malaria","volume":"7","author":"Barboza","year":"2017","journal-title":"Sci Rep."},{"key":"B87","volume-title":"(12) United States Patent","author":"Hawkins","year":"2001"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1128\/CVI.00153-07","article-title":"Synthetic toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome","volume":"14","author":"Morefield","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1021\/jm301694x","article-title":"Identification of substituted pyrimido[5,4-b]indoles as selective tolllike receptor 4 ligands","volume":"56","author":"Chan","year":"2013","journal-title":"J Med Chem."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1128\/JVI.03337-14","article-title":"Synthetic toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","volume":"89","author":"Goff","year":"2015","journal-title":"J Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/mol.105.019695","article-title":"A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4- fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK- 242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling","volume":"69","author":"Ii","year":"2006","journal-title":"Mol Pharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","article-title":"Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model","volume":"157","author":"Takashima","year":"2009","journal-title":"Br J Pharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2217\/14796678.1.6.785","article-title":"Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligand","volume":"1","author":"Miller","year":"2005","journal-title":"Fut Cardiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1159\/000471248","article-title":"TAK-242 protects against apoptosis in coronary microembolization-induced myocardial injury in rats by suppressing TLR4\/NF-\u03baB signaling pathway","volume":"41","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1021\/ar00089a003","article-title":"Calixarenes","volume":"16","author":"Gutsche","year":"1983","journal-title":"Acc Chem Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1039\/p19890002039","article-title":"Syntheses and aggregation properties of new water-soluble calixarenes","volume":"1","author":"Shinkai","year":"1989","journal-title":"J Chem Soc Perkin Transac."},{"key":"B98","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1039\/C2CS35233H","article-title":"Biological applications of functionalized calixarenes","volume":"42","author":"Nimse","year":"2013","journal-title":"Chem Soc Rev."},{"key":"B99","first-page":"16","article-title":"Calixarenes and cucurbiturils: pharmaceutial and biomedical applications","volume":"4","author":"Saluja","year":"2013","journal-title":"J Pharm Educ Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1021\/jm0610447","article-title":"Topomimetics of amphipathic \u03b2-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins","volume":"49","author":"Chen","year":"2006","journal-title":"J Med Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/mp.2014.177","article-title":"DAT isn't all that: cocaine reward and reinforcement require toll-like receptor 4 signaling","volume":"20","author":"Northcutt","year":"2015","journal-title":"Mol Psychiatry"},{"key":"B102","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/bph.13394","article-title":"Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4","volume":"173","author":"Wang","year":"2016","journal-title":"Br J Pharmacol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.4049\/jimmunol.174.2.1091","article-title":"Phospholipids inhibit Lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein","volume":"174","author":"Mueller","year":"2005","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"ra95","DOI":"10.1126\/scisignal.aaa6179","article-title":"Dichotomous roles for externalized cardiolipin in extracellular signaling: promotion of phagocytosis and attenuation of innate immunity","volume":"8","author":"Balasubramanian","year":"2015","journal-title":"Sci Signal."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1007\/s00018-019-03113-5","article-title":"Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4","volume":"76","author":"Pizzuto","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4049\/jimmunol.181.2.1245","article-title":"Elucidation of the MD-2\/TLR4 interface required for signaling by lipid IVa","volume":"181","author":"Walsh","year":"2008","journal-title":"J Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.intimp.2011.11.017","article-title":"Traditional medicine alpinetin inhibits the inflammatory response in Raw 264","volume":"12","author":"Huo","year":"2012","journal-title":"Int Immunopharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2013.09.049","article-title":"Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-\u03b3 in THP-1-derived macrophages","volume":"721","author":"Hu","year":"2013","journal-title":"Eur J Pharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.intimp.2018.07.010","article-title":"Alpinetin ameliorates inflammatory response in LPS-induced endometritis in mice","volume":"62","author":"Liang","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.imbio.2015.11.001","article-title":"The molecular events behind ferulic acid mediated modulation of IL-6 expression in LPS-activated Raw 264","volume":"221","author":"Lampiasi","year":"2016","journal-title":"Immunobiology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.biopha.2018.01.169","article-title":"Ferulic acid protects lipopolysaccharide-induced acute kidney injury by suppressing inflammatory events and upregulating antioxidant defenses in Balb\/c mice","volume":"100","author":"Mir","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B112","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.rvsc.2019.08.018","article-title":"Ferulic acid inhibits bovine endometrial epithelial cells against LPS-induced inflammation via suppressing NK-\u03baB and MAPK pathway","volume":"126","author":"Yin","year":"2019","journal-title":"Res Vet Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3389\/fimmu.2019.01000","article-title":"Regulation of toll-like receptor (TLR) signaling pathway by polyphenols in the treatment of age-linked neurodegenerative diseases: focus on TLR4 signaling","volume":"10","author":"Azam","year":"2019","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T08:27:06Z","timestamp":1667377626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":113,"alternative-id":["10.3389\/fimmu.2020.01210"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01210","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"article-number":"1210"}}